CCXI ChemoCentryx, Inc.

NASDAQ
$11.62

ChemoCentryx, Inc. (CCXI) is expected to report earnings on May 4, 2023, after the market close.

Earnings Date
May 4
Thursday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ChemoCentryx, Inc.

Chemocentryx Inc is a biopharmaceutical company engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.